Showing 201 - 220 results of 1,358 for search 'treating modification', query time: 0.10s Refine Results
  1. 201

    Topical Application of RNAi Therapy Using Surface-Modified Liposomes for Treating Retinal-Vein Occlusion by Taishi Shiratori, Takaaki Ito, Anri Nishinaka, Ryosuke Matsumiya, Eriko Yamazoe, Hirofumi Takeuchi, Hideaki Hara, Kohei Tahara

    Published 2025-06-01
    “…In this study, we present a novel approach to treating retinal diseases using eye drops that contain PnkRNA, a single-stranded RNA nucleic acid. …”
    Get full text
    Article
  2. 202

    The performance of chemically and physically modified local kaolinite in methanol dehydration to dimethyl ether by Sanaa M. Solyman, Mohamed A. Betiha

    Published 2014-09-01
    “…Natural kaolinite (KN) was treated chemically with H2O2 (KT) followed by thermal treatment at 500 °C (KC) and then mechano-chemically by ball milling with and without CaSO4 (KB-Ca and KB, respectively). …”
    Get full text
    Article
  3. 203

    Comparative Study Between Native and Modified Starches Isolated from Tamarind Seed by Tripathi Shalvika, Akansha, Shaida Bushra

    Published 2025-01-01
    “…Seeds represent a potential source of starch, containing at least 60–70% of total starch, however many of them are treated as waste and are usually discarded. Tamarind seeds known to be high in Xyloglycan. …”
    Get full text
    Article
  4. 204

    METTL3 promotes podocyte pyroptosis in diabetic nephropathy through N6-methyladenosine modification of TRIM29 mRNA by Xiaohong Xu, Xiaolin Huang, Ce Zhang, Xia Mi, Chi Zhang, Fei Hua, Liexiang Zhang

    Published 2025-12-01
    “…Our results suggest that METTL3 plays a critical role in hyperglycemia-induced podocyte injury through m6A modification of TRIM29 mRNA, which provides new insight for the development of METTL3- and pyroptosis-targeted strategies to treat DN and other diabetic kidney diseases.…”
    Get full text
    Article
  5. 205

    Esculetin inhibits ferroptosis after ICH by promoting NUDT1-mediated m7G methylation modification of GPX4 by Jinbing Gong, Zhanwei Zhang, Libo Li, Zhigang Mei, Tao Chen

    Published 2025-08-01
    “…Inhibiting ferroptosis after ICH will effectively treat ICH and improve prognosis. Esculetin is the main active ingredient of the Chinese medicine Cortex Fraxini, which has neuroprotective effects. 7-methylguanosine (m7G) methylation is a common RNA modification that regulates mRNA stability and translation, playing an important role in neural development and function, as well as in ferroptosis-related pathways. …”
    Get full text
    Article
  6. 206

    RBM15 promotes hypoxia/reoxygenation-induced ferroptosis in human cardiomyocytes by mediating m6A modification of ACSL4 by Yi Cheng, Jiamin Wan, Yingyue Xu, Shasha Liu, Linfeng Li, Jing Zhou, Fuyan Xie

    Published 2025-07-01
    “…Methods and results AC16 cells were treated with hypoxia/reoxygenation (H/R) to establish an in vitro myocardial infarction cell model. …”
    Get full text
    Article
  7. 207

    Effectiveness and Safety of CGRP-Targeted Therapies Combined with Lifestyle Modifications for Chronic Migraine in Korean Pediatric Patients: A Retrospective Study by Ji-Hoon Na, Hayoon Jeon, Ji-Eun Shim, Hyunjoo Lee, Young-Mock Lee

    Published 2025-05-01
    “…This study evaluated the safety and efficacy of CGRP-targeted therapies combined with structured lifestyle modifications in Korean pediatric patients with CM. <b>Methods:</b> This retrospective study examined 10 pediatric CM patients treated at Gangnam Severance Hospital from 2021 to 2024. …”
    Get full text
    Article
  8. 208

    Assessment of dental professionals' preparedness for treating patients with special health care needs in Lahore, Pakistan by Wajiha Alamgir, Uzma Jabbar Khan, Zubair Maqsood, Sultan Muhammad Sarang, Kashif Siddique

    Published 2024-06-01
    “…Frequent interactions with SHCN patients were reported by 23.6% (n=52), and 55.5% (n=122) believed there was insufficient experience among dental practitioners in treating these patients. CONCLUSION: The study highlighted a significant knowledge gap and perceived challenges in treating SHCN patients among general dentists. …”
    Get full text
    Article
  9. 209
  10. 210
  11. 211
  12. 212
  13. 213
  14. 214

    Enhanced Performance of a Microbial Fuel Cell Using Double Oxidant-Treated Carbon Felts by Bhavi Pandya, Latesh Chaudhari, Naresh R. Vaghela

    Published 2025-03-01
    “…Utilizing double oxidant-treated carbon felts in MFC applications increased current density to 749.56 mA/m<sup>2</sup> and increased peak power density to 125.23 mW/m<sup>2</sup>. …”
    Get full text
    Article
  15. 215

    The effects of wetting-drying and freezing-thawing cycles on mechanical properties of biopolymer-fiber treated soil by Dianzhi Feng, Yong Wan, Jiaxu Jin, Xingxing He, Bing Liang, Qiang Xue

    Published 2025-04-01
    “…Biopolymer-fiber treated soil has great application potential in civil engineering with better mechanical properties and environmental sustainability. …”
    Get full text
    Article
  16. 216

    Investigating the Histological Changes in Heart, Lung, Liver and Kidney of Male Albino Mice Treated with Ivabradine by Hadeel Kamil Khaleel

    Published 2019-09-01
    “…In Kidney, there are no histopathological modifications in the tissue after the animals treated with 10 mg\kg of Ivabradine. …”
    Get full text
    Article
  17. 217

    CD19 -targeted CAR T therapy treating hematologic malignancies: hidden danger is the next neighbor to security? by Xueshuai Ye, Min Ge, Mengtian Tan, Yongqiang Wu, Haiqiang Zhang, Zexian Fu

    Published 2025-03-01
    “…In this review, we summarize the short- and long-term toxicity, such as secondary T-cell tumors and lethal CAR tumors, of patients with hematologic malignancies treated with CD19-CAR-T cells, including cytokine release syndrome (CRS), ICANS, and secondary malignancies with low occurrence rates but high mortality, such as secondary T cell tumors and lethal CAR tumors, which may be related to the gene modification mechanism of viral vectors currently approved for CAR-T cells. …”
    Get full text
    Article
  18. 218

    The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review by Elena Pezzolo, Sara Di Leo, Paola Miceli, Alvise Sernicola, Luigi Naldi

    Published 2025-07-01
    “…Mesenchymal stem cell (MSC) therapy holds promise for treating immune-mediated inflammatory skin diseases (IMIDs), particularly when conventional therapies are ineffective. …”
    Get full text
    Article
  19. 219
  20. 220

    Stem cell-derived exosome delivery systems for treating atherosclerosis: The new frontier of stem cell therapy by Hassan Tariq, Syeda Zunaira Bukhari, Ruibing An, Jian Dong, Ayesha Ihsan, Muhammad Rizwan Younis

    Published 2025-02-01
    “…The design engineering of exosomes has been summarized to present how drug loading and surface modification with targeting ligands can improve the therapeutic and targeting capacity of exosomes, demonstrating atheroprotective action. …”
    Get full text
    Article